Apply for a grant
Applications are now closed. Application deadlines for 2018 will be announced shortly.
To be eligible for the Pancreatic Cancer Action’s (PCA) Early Diagnosis Challenge Award the research MUST focus on improving early diagnosis of pancreatic cancer. We encourage applications for projects that could, for example:
- Explore a novel approach to diagnosis;
- Investigate areas of unexplored potential;
- Focus on the novel application of technology;
- Grow and access a rich patient/sample cohort;
- Have potential for further funding after proof of concept.
- The principle investigator must reside in the UK and be from a UK university, hospital, Clinical Trials Unit or a research institution affiliated to one of these institutions.
- The project and any associated employment must also take place in the UK.
- The applicant should have a strong academic track record in the field of cancer, particularly pancreatic cancer.
- The award cannot be used to fund salaries of principle or co-investigator salaries.
- The award can be used for projects with or without associated salary costs.
- The award cannot be used to fund a PhD student stipend.
- PCA will not consider applications from a commercial entity.
- PCA will not consider applications for project grants to cover equipment, consumables or running costs only. No equipment over £5,000 will be funded.
Applications will only be considered for research into improving the early diagnosis of pancreatic cancer.
Applications will be evaluated by our Scientific Advisory Committee (SAC) on scientific merit and compliance with our research strategy.
- The maximum period of support will be 24 months.
- The maximum value of the grant is £40,000.
- The project must start within 3 months of the proposed start date. (When applying, do be realistic about the start date, allowing time for ethics approval, recruitment etc).
- Payment will be quarterly in arrears.
- 10% of the grant value will be held back until both the end of grant research and finance reports are received by Pancreatic Cancer Action.
- PCA will require research updates at least every 6 months detailing progress against research milestones outlined in the original application.